Here are relevant reports on : ultrasound-transducer-market
-
Portable Ultrasound Market by Product (Probes, System & Console, Software, Service), Platform (Trolley/Cart, Handheld, Laptop/Tablet), Application (Trauma, OB/GYN, Cardio, Vascular, Pediatric), End User (Hospital, Imaging Centers) - Global Forecast to 2030
The global portable ultrasound market, valued at US$2.16 billion in 2023, stood at US$2.49 billion in 2025 and is projected to advance at a resilient CAGR of 9.0% from 2025 to 2030, culminating in a forecasted valuation of US$3.84 billion by the end of the period. The portable ultrasound market is experiencing significant growth due to several key factors.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024
The Lymphedema Diagnostics Market is expected to grow from USD 24 million in 2019 to USD 35 million by 2024, at a CAGR of 7.4% during the forecast period. The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany). Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Cardiac Ablation Market by Technology (Radiofrequency, Electrical, Cryoablation, Ultrasound, Microwave), Product (Irreversible Electroporation, HIFU, MRgFUS), Application (Cardiac Arrhythmia, Atrial Fibrillation, Tachycardia, Open Surgery) - Global Forecast to 2019
The global cardiac ablation market is poised to grow at a CAGR of 12.5% during 2014-2019, and is expected to reach a value of ~$883.1 Million in 2019. A number of factors such as growing geriatric population coupled with increasing population base of cardiovascular disease patients, technological advancements in the field of ablation devices, and growing awareness about benefits of cardiac ablation procedures over conventional therapeutic and surgical procedures are fuelling the growth of the global cardiac ablation market. However, high cost-containment measures taken by various governments and ongoing healthcare reforms in the U.S. are some of the key factors hampering the market growth.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Interventional Radiology Imaging Market by Product (MRI System, Ultrasound Imaging System, CT Scanner, Angiography System), Procedures (Angiography, Angioplasty, Biopsy) & Application (Cardiology, Oncology, Urology & Nephrology) - Global Forecast to 2021
The global interventional radiology imaging market is projected to grow at a CAGR of 6.7%. This market is segmented based on product, procedure, and application. A number of factors, such as rising incidence and prevalence of chronic diseases, increasing demand for minimally invasive procedures, technological advancements are expected to drive the growth of this market.
- Published: March 2017
- Price: $ 4950
- TOC Available:
-
Electrophysiology Market by Product (Lab Devices (3D Mapping, Recording, ICE, X-ray Systems), Ablation Catheters (Cryoablation, Radiofrequency, Laser, Microwave), Diagnostic Catheters (Conventional, Advanced, Ultrasound)), End Use-Global Forecast to 2030
The global electrophysiology market, valued at US$11.41 billion in 2024, stood at US$12.55 billion in 2025 and is projected to advance at a resilient CAGR of 11.6% from 2025 to 2030, culminating in a forecasted valuation of US$21.72 billion by the end of the period. The rise of the electrophysiology market can be attributed to several drivers: the increasing prevalence of cardiovascular diseases, including arrhythmias and atrial fibrillation; patients and healthcare providers are increasingly favoring minimally invasive procedures over traditional surgical interventions; electrophysiological techniques, such as catheter ablation, offer less invasive options for treating certain cardiac arrhythmias; and government support and initiatives aimed at improving healthcare infrastructure and funding research and development in electrophysiology also contribute to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Ophthalmic Imaging Market by Product Type (Optical Coherence Tomography Systems, Ophthalmic Ultrasound Systems, Fundus Cameras), Application (Glaucoma, Retinopathies), End User (Hospitals, Ophthalmology Clinics, Optometry Clinics) - Global Forecast to 2030
The global ophthalmic imaging market, valued at US$2.7 billion in 2024, stood at US$2.8 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$3.8 billion by the end of the period. The ophthalmic imaging market is driven by the rising prevalence of eye diseases and an aging global population, which boosts demand for advanced diagnostic tools.
- Published: August 2025
- Price: $ 4950
- TOC Available:
-
US Medical Simulation Market by offering (Anatomical Models [Patient {High Fidelity}, Surgical {Laparoscopic, Ortho, Gynec, Spine}, Trainers, Ultrasound], Software), Technology (3D Printing, Virtual Patient, Procedural Rehearsal), End User - Forecast 2030
The US Medical Simulation market, valued at USD 1.20 billion in 2024, stood at USD 1.40 billion in 2025 and is projected to advance at a resilient CAGR of 15.2% from 2025 to 2030, culminating in a forecasted valuation of USD 2.83 billion by the end of the period. The US medical simulation market continues to expand, supported by rising demand for advanced clinical training, stricter regulatory and accreditation requirements, and a growing healthcare workforce.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Biopsy Devices Market by Product (Core needle biopsy (Automatic, Disposable), Technology (Ultrasound,stereotactic), Application (Oncology, Gastroenterology, Bone & Bone marrow biopsy), End User (Diagnostic imaging centres) - Global Forecast to 2030
The global biopsy devices market, valued at US$6.86B in 2023, is forecasted to grow at a 7.2% CAGR, reaching US$7.27B by 2024 and US$11.01B by 2030. The rising prevalence of cancer. Additionally the increasing preference for minimally invasive surgeries. Moreover, the improved reimbursement policies is likely to promote the growth of biopsy device market.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Food Ultrasound Market by Frequency Range (High-intensity and Low-intensity), Food Product (Meat, Beverages, F&V, Dairy, Bakery), Function (Microbial Inactivation, Quality Assurance, Homogenization, Cutting), and Region - Global forecast to 2022
The food ultrasound market was valued at USD 87.7 Million in 2016. It is projected to reach USD 134.6 Million by 2022, growing at a CAGR of 7.5% from 2017. Ultrasound technology is used for the processing of various food products such as meat & food, fruits & vegetables, beverages, dairy, bakery & confectionery, and others (cereals, grains, pulses, nuts, seeds, spices, and packaged foods). This report includes a study of the business strategies, along with the product portfolios of leading companies. It includes the profiles of leading companies such as Bosch (Germany), Emerson (US), Bühler (Switzerland), Dukane (US), and Heilscher (Germany).
- Published: March 2018
- Price: $ 4950
- TOC Available:
-
Non Invasive Prenatal Testing Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs) - Global Forecasts to 2029
The global non invasive prenatal testing market, valued at US$6.4 billion in 2023, stood at US$7.2 billion in 2024 and is projected to advance at a resilient CAGR of 14.5% from 2024 to 2029, culminating in a forecasted valuation of US$14.1 billion by the end of the period. The primary growth factors propelling this market include spiking investments, incentives, and support from both state governments and private companies, which are driving access to and demand for NIPT technologies.
- Published: September 2024
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
